Eric Jordan
About Eric Jordan
Eric Jordan is the Executive Director at Supernus Pharmaceuticals, Inc., where he collaborates with senior leadership across various business functions to develop strategies and programs. He has extensive experience in the pharmaceutical industry, having held multiple leadership roles at Shire and achieved recognition for his contributions to sales and market access.
Work at Supernus Pharmaceuticals
Eric Jordan has been serving as the Executive Director at Supernus Pharmaceuticals, Inc. since 2019. In this role, he collaborates with C-Suite, Senior Vice Presidents, and Vice Presidents across various business functions, including marketing, sales, finance, research and development, medical, and business development. His responsibilities include devising strategies and programs that align with the company's objectives.
Previous Experience at Shire
Prior to his current role, Eric Jordan held multiple positions at Shire, contributing to various aspects of the organization. He served as the Director of Global Market Access for the Neuroscience Business Unit from 2013 to 2015. He also worked as the VP of Payer and Institutional Strategy Lead from 2015 to 2019. His earlier roles included Director of Government Marketing, Southeast Zone Director, Regional Director, and Associate Director/Director of Sales Force Effectiveness, spanning from 2000 to 2013.
Education and Expertise
Eric Jordan earned a Bachelor of Science degree in Biological Sciences from Clemson University, where he studied from 1994 to 1998. His educational background supports his extensive experience in the pharmaceutical industry, particularly in therapeutic launches across various areas such as Hematology, Oncology, and CNS. He has also served as a payer lead in specialized fields, demonstrating his expertise in developing strategic plans that enhance patient access.
Achievements in Sales and Strategy
Throughout his career, Eric Jordan has achieved notable recognition for his contributions to sales and strategy. He has been awarded the President’s Club honor, which is given to the top 5% of the sales organization, in four consecutive positions. His proven track record includes developing strategic plans that have significantly contributed to net sales while ensuring patient access across a wide range of therapeutic areas.